The Role of Chemokines in Leucocyte-stromal Interactions in Rheumatoid Arthritis

Overview

Journal Front Biosci

Specialty Biology

Date 2007 Nov 6

PMID 17981742

Citations 12

Authors

Andrew Filer

Karim Raza

Mike Salmon

Christopher D Buckley

Affiliations

Soon will be listed here.

Abstract

New dimensions in our understanding of immune cell trafficking in health and disease have been opened by the discovery of chemokines and their receptors. This family of chemo-attractant cytokines performs essential roles in the recruitment and subsequent positioning of leucocyte subsets within tissue microenvironments. Investigation of chemokine networks offers a novel approach to understand the mechanisms by which inflammatory cells persist in diseases such as rheumatoid arthritis (RA), where evidence is mounting that the inappropriate temporal and spatial expression of chemokines and/or their receptors may impair the resolution of leucocyte infiltrates. The recognition that stromal cells such as fibroblasts, as active components of tissue specific microenvironments, are able to determine the type and persistence of inflammatory infiltrates has opened new vistas in research. Stromal cells are active contributors to cytokine and inflammatory chemokine networks which result in immune cell recruitment and activation. However an intriguing role of stromal cells has been demonstrated in the inappropriate expression of constitutive, housekeeping chemokines, which contribute to the persistence of inflammation by actively blocking its resolution.

Citing Articles

The forgotten key players in rheumatoid arthritis: IL-8 and IL-17 - Unmet needs and therapeutic perspectives.

Gremese E, Tolusso B, Bruno D, Perniola S, Ferraccioli G, Alivernini S Front Med (Lausanne). 2023; 10:956127.

PMID: 37035302 PMC: 10073515. DOI: 10.3389/fmed.2023.956127.

Stromal and Immune Cell Dynamics in Tumor Associated Tertiary Lymphoid Structures and Anti-Tumor Immune Responses.

Rossi A, Belmonte B, Carnevale S, Liotti A, De Rosa V, Jaillon S Front Cell Dev Biol. 2022; 10:933113.

PMID: 35874810 PMC: 9304551. DOI: 10.3389/fcell.2022.933113.

Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications.

Maurya S, Khan P, Rehman A, Kanchan R, Perumal N, Mahapatra S Semin Cancer Biol. 2021; 86(Pt 3):914-930.

PMID: 34968667 PMC: 9234104. DOI: 10.1016/j.semcancer.2021.12.009.

Fibroblast subtypes in tissues affected by autoimmunity: with lessons from lymph node fibroblasts.

Shipman W, Sandoval M, Veiga K, Donlin L, Lu T Curr Opin Immunol. 2020; 64:63-70.

PMID: 32387902 PMC: 7963142. DOI: 10.1016/j.coi.2020.03.002.

Fibroblast activation and inflammation in frozen shoulder.

Akbar M, McLean M, Garcia-Melchor E, Crowe L, McMillan P, Fazzi U PLoS One. 2019; 14(4):e0215301.

PMID: 31013287 PMC: 6478286. DOI: 10.1371/journal.pone.0215301.

References

Kasama T, Strieter R, Lukacs N, Lincoln P, Burdick M, Kunkel S . Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest. 1995; 95(6):2868-76. PMC: 295974. DOI: 10.1172/JCI117993. View

Pilling D, Akbar A, Girdlestone J, Orteu C, Borthwick N, Amft N . Interferon-beta mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol. 1999; 29(3):1041-50. DOI: 10.1002/(SICI)1521-4141(199903)29:03<1041::AID-IMMU1041>3.0.CO;2-#. View

Hosaka S, Akahoshi T, Wada C, Kondo H . Expression of the chemokine superfamily in rheumatoid arthritis. Clin Exp Immunol. 1994; 97(3):451-7. PMC: 1534851. DOI: 10.1111/j.1365-2249.1994.tb06109.x. View

Patel D, Zachariah J, Whichard L . CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. Clin Immunol. 2001; 98(1):39-45. DOI: 10.1006/clim.2000.4957. View

Salmon M, Gaston J . The role of T-lymphocytes in rheumatoid arthritis. Br Med Bull. 1995; 51(2):332-45. DOI: 10.1093/oxfordjournals.bmb.a072964. View

Tamamura H, Fujisawa M, Hiramatsu K, Mizumoto M, Nakashima H, Yamamoto N . Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent. FEBS Lett. 2004; 569(1-3):99-104. DOI: 10.1016/j.febslet.2004.05.056. View

Chabaud M, Page G, Miossec P . Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol. 2001; 167(10):6015-20. DOI: 10.4049/jimmunol.167.10.6015. View

Paulus H, Machleder H, Levine S, Yu D, MACDONALD N . Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum. 1977; 20(6):1249-62. DOI: 10.1002/art.1780200614. View

Middleton J, Patterson A, Gardner L, Schmutz C, Ashton B . Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood. 2002; 100(12):3853-60. DOI: 10.1182/blood.V100.12.3853. View

10.

Firestein G . Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum. 1996; 39(11):1781-90. DOI: 10.1002/art.1780391103. View

11.

Postlethwaite A, Shigemitsu H, Kanangat S . Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol. 2004; 16(6):733-8. DOI: 10.1097/01.bor.0000139310.77347.9c. View

12.

Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N . Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. Arthritis Rheum. 2005; 52(10):3004-14. DOI: 10.1002/art.21301. View

13.

Fan L, Reilly C, Luo Y, Dorf M, Lo D . Cutting edge: ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis. J Immunol. 2001; 164(8):3955-9. DOI: 10.4049/jimmunol.164.8.3955. View

14.

Bazan J, Bacon K, Hardiman G, Wang W, Soo K, Rossi D . A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997; 385(6617):640-4. DOI: 10.1038/385640a0. View

15.

Nanki T, Hayashida K, El-Gabalawy H, Suson S, Shi K, Girschick H . Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol. 2000; 165(11):6590-8. DOI: 10.4049/jimmunol.165.11.6590. View

16.

Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y . Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006; 203(12):2673-82. PMC: 2118166. DOI: 10.1084/jem.20061775. View

17.

Szekanecz Z, Koch A . Chemokines and angiogenesis. Curr Opin Rheumatol. 2001; 13(3):202-8. DOI: 10.1097/00002281-200105000-00009. View

18.

Godessart N, Kunkel S . Chemokines in autoimmune disease. Curr Opin Immunol. 2001; 13(6):670-5. DOI: 10.1016/s0952-7915(01)00277-1. View

19.

Koch A . Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis. 2003; 62 Suppl 2:ii60-7. PMC: 1766740. DOI: 10.1136/ard.62.suppl_2.ii60. View

20.

Edwards J . Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis. Arthritis Res. 2000; 2(5):344-7. PMC: 130134. DOI: 10.1186/ar110. View